OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia
Chen Zhang, Mei‐Juan Chen, Guojun Wu, et al.
The Journal of Clinical Psychiatry (2016) Vol. 77, Iss. 11, pp. e1460-e1466
Closed Access | Times Cited: 22

Showing 22 citing articles:

Evidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for Psychopharmacology
Thomas R. E. Barnes, Richard Drake, Carol Paton, et al.
Journal of Psychopharmacology (2019) Vol. 34, Iss. 1, pp. 3-78
Open Access | Times Cited: 513

Clozapine as a first‐ or second‐line treatment in schizophrenia: a systematic review and meta‐analysis
Cynthia Okhuijsen‐Pfeifer, Elianne A. H. Huijsman, A. Hasan, et al.
Acta Psychiatrica Scandinavica (2018) Vol. 138, Iss. 4, pp. 281-288
Open Access | Times Cited: 73

Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha
Chen Zhang, Xinyu Fang, Pei-Fen Yao, et al.
Psychoneuroendocrinology (2017) Vol. 81, pp. 138-143
Closed Access | Times Cited: 61

Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study
Yi Zhang, Xinyu Fang, Weixing Fan, et al.
Psychopharmacology (2018) Vol. 235, Iss. 4, pp. 1191-1198
Closed Access | Times Cited: 52

Demographic and clinical features as predictors of clozapine response in patients with schizophrenia spectrum disorders: A systematic review and meta-analysis
Cynthia Okhuijsen‐Pfeifer, A.Y. Sterk, Ingrid Horn, et al.
Neuroscience & Biobehavioral Reviews (2020) Vol. 111, pp. 246-252
Open Access | Times Cited: 37

Effects of omega-3 fatty acids on metabolic syndrome in patients with schizophrenia: a 12-week randomized placebo-controlled trial
Feikang Xu, Weixing Fan, Weiping Wang, et al.
Psychopharmacology (2018) Vol. 236, Iss. 4, pp. 1273-1279
Open Access | Times Cited: 32

Prescribing pattern of antipsychotic medication for first-episode psychosis: a retrospective cohort study
Dolores Keating, Stephen McWilliams, Fiona Boland, et al.
BMJ Open (2021) Vol. 11, Iss. 1, pp. e040387-e040387
Open Access | Times Cited: 21

A Chart Audit Study of Clozapine Utilization in Early Psychosis
Louis-David Leclerc, Marie‐France Demers, Andrea Bardell, et al.
Journal of Clinical Psychopharmacology (2021) Vol. 41, Iss. 3, pp. 275-280
Closed Access | Times Cited: 13

Antipsychotic dopamine D2 affinity and negative symptoms in remitted first episode psychosis patients
Franciska de Beer, Ben Wijnen, Lotte Wouda, et al.
Schizophrenia Research (2024) Vol. 274, pp. 299-306
Open Access | Times Cited: 1

A Random Forest Model for Predicting Social Functional Improvement in Chinese Patients with Schizophrenia After 3 Months of Atypical Antipsychotic Monopharmacy: A Cohort Study
Yange Li, Lei Zhang, Yan Zhang, et al.
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 847-857
Open Access | Times Cited: 9

Genetic association analysis of microRNA137 and its target complex 1 with schizophrenia in Han Chinese
Weihong Lu, Yi Zhang, Xinyu Fang, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 9

Treatment strategies in management of schizophrenia patients with persistent symptoms in daily practice: a retrospective study
Ahmet Kokurcan, Seher Olga Güriz, Hasan Karadağ, et al.
International Journal of Psychiatry in Clinical Practice (2021) Vol. 25, Iss. 3, pp. 238-244
Closed Access | Times Cited: 7

Kynurenine pathway metabolites and therapeutic response to olanzapine in female patients with schizophrenia: A longitudinal study
Xiaoni Guan, Jing Xu, Meihong Xiu, et al.
CNS Neuroscience & Therapeutics (2022) Vol. 28, Iss. 10, pp. 1539-1546
Open Access | Times Cited: 5

Precise treatments for schizophrenia: where is the way forward?
Chen Zhang, Yemeng Mao, Lisheng Song
General Psychiatry (2018) Vol. 31, Iss. 1, pp. e000002-e000002
Open Access | Times Cited: 6

Trajectories of response in schizophrenia-spectrum disorders: A one-year prospective cohort study of antipsychotic effectiveness
Petros Drosos, Erik Johnsen, Christoffer Bartz‐Johannessen, et al.
World Journal of Psychiatry (2022) Vol. 12, Iss. 3, pp. 521-532
Open Access | Times Cited: 4

Effects of olanzapine on anhedonia in schizophrenia: mediated by complement factor H
Yi Zhang, Wei Tang, Weiping Wang, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 2

Evaluation of paliperidone on social function in patients with chronic schizophrenia
Yan Gu, Hong Peng, Dai Jing-jing, et al.
General Psychiatry (2018) Vol. 31, Iss. 2, pp. e000011-e000011
Open Access | Times Cited: 4

The involvement of family members in the treatment of patients with schizophrenia
Chen Zhang
Current Treatment Options in Psychiatry (2016) Vol. 3, Iss. 2, pp. 111-118
Closed Access | Times Cited: 2

Optimizing recovery in first-episode psychosis: A systematic review of psychosocial interventions
Madisen T. Russell, Imani S. Linton, Jenifer L. Vohs, et al.
Schizophrenia Research (2024) Vol. 275, pp. 166-178
Closed Access

Associations of Clozapine Use With Psychosocial Functioning and Quality of Life in Patients With Schizophrenia: A Community-Based Cross-Sectional Study
S. Kim, Seoyoung Kim, Ah Young Choe, et al.
Psychiatry Investigation (2021) Vol. 18, Iss. 10, pp. 968-976
Open Access | Times Cited: 3

A Scoping Review of Patient Support Program Services Across Diverse Settings and Disease Areas Described from a People-Centered Perspective
Angela Riveroll, Patricia Charlton, Evelyn Pyper, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 1

Page 1

Scroll to top